Skip to main content
Premium Trial:

Request an Annual Quote

Genaissance Stock Slides 6.5 Percent on News of Stock Placement

This article has been updated from an earlier version to inlcude share price.

NEW YORK , Nov. 19 (GenomeWeb News) - Shares in Genaissance Pharmaceuticals were down 6.5 percent at $1.58 in mid-afternoon trade after the company said it will try to generate $6 million from a private stock placement.

 

The New Haven, Conn.-based pharmacogenomics company this morning said it will issue 3.55 million shares of common stock and warrants for another 3.55 million shares to undisclosed institutional investors and other accredited investors.

 

Genaissance said it will use the proceeds for general corporate purposes, including the repayment of debt.

 

The private placement, which the company said it expects to close this afternoon, comes after announcing earlier this week a  layoff of 10 percent of its workforce in an attempt to reach break even from operations.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.